Pharmaceutical preparations for the treatment of mitochondrial diseases, namely, primary and secondary mitochondrial diseases; Pharmaceutical preparations for the treatment of diseases and conditions with mitochondrial dysfunction, namely, altered redox status, increased reactive oxygen species, and inflammation

Pharmaceutical preparations for the treatment of mitochondrial diseases; pharmaceutical preparations for the treatment of diseases and conditions with altered redox status or increased reactive oxygen species